The first prospective trial for von Hippel-Lindau disease: pazopanib.

Lancet Oncol

Department of Neurosurgery, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Published: October 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30533-3DOI Listing

Publication Analysis

Top Keywords

prospective trial
4
trial von
4
von hippel-lindau
4
hippel-lindau disease
4
disease pazopanib
4
prospective
1
von
1
hippel-lindau
1
disease
1
pazopanib
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!